These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 22192934)

  • 1. [Renal involvement in systemic lupus erythematosus].
    Karras A
    Presse Med; 2012 Mar; 41(3 Pt 1):260-6. PubMed ID: 22192934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
    Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Baldovino S; Menegatti E; La Grotta R; Modena V
    Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study.
    Boletis JN; Marinaki S; Skalioti C; Lionaki SS; Iniotaki A; Sfikakis PP
    Nephrol Dial Transplant; 2009 Jul; 24(7):2157-60. PubMed ID: 19179411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab in the treatment of resistant lupus nephritis: therapy failure in rapidly progressive crescentic lupus nephritis.
    Davies RJ; Sangle SR; Jordan NP; Aslam L; Lewis MJ; Wedgwood R; D'Cruz DP
    Lupus; 2013 May; 22(6):574-82. PubMed ID: 23632989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
    Fanouriakis A; Kostopoulou M; Cheema K; Anders HJ; Aringer M; Bajema I; Boletis J; Frangou E; Houssiau FA; Hollis J; Karras A; Marchiori F; Marks SD; Moroni G; Mosca M; Parodis I; Praga M; Schneider M; Smolen JS; Tesar V; Trachana M; van Vollenhoven RF; Voskuyl AE; Teng YKO; van Leew B; Bertsias G; Jayne D; Boumpas DT
    Ann Rheum Dis; 2020 Jun; 79(6):713-723. PubMed ID: 32220834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rituximab vs mycophenolate and vs cyclophosphamide pulses for induction therapy of active lupus nephritis: a clinical observational study.
    Moroni G; Raffiotta F; Trezzi B; Giglio E; Mezzina N; Del Papa N; Meroni P; Messa P; Sinico AR
    Rheumatology (Oxford); 2014 Sep; 53(9):1570-7. PubMed ID: 24505125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring new territory: the move towards individualised treatment.
    Haubitz M
    Lupus; 2007; 16(3):227-31. PubMed ID: 17432112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lupus nephritis: up-to-date].
    Karras A
    Rev Med Interne; 2015 Feb; 36(2):98-106. PubMed ID: 25443980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modern therapeutic strategies for paediatric systemic lupus erythematosus and lupus nephritis.
    Marks SD; Tullus K
    Acta Paediatr; 2010 Jul; 99(7):967-74. PubMed ID: 20222881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Lupus-nephritis--diagnosis and treatment].
    Norby GE; Lerang K; Holdaas H; Gran JT; Strøm EH; Draganov B; Os I; Hartmann A; Gilboe IM
    Tidsskr Nor Laegeforen; 2010 Jun; 130(11):1140-4. PubMed ID: 20531500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic thrombocytopenic purpura and systemic lupus erythematosus: a rare and life-threatening association.
    El Khayat SS; Medkouri G; Etomba AM; Zamd M; Gharbi MB; Ramadani B
    Arab J Nephrol Transplant; 2012 May; 5(2):103-5. PubMed ID: 22612197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease.
    Salvatore SP; Barisoni LM; Herzenberg AM; Chander PN; Nickeleit V; Seshan SV
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):914-25. PubMed ID: 22461531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histopathologic and clinical outcome of rituximab treatment in patients with cyclophosphamide-resistant proliferative lupus nephritis.
    Gunnarsson I; Sundelin B; Jónsdóttir T; Jacobson SH; Henriksson EW; van Vollenhoven RF
    Arthritis Rheum; 2007 Apr; 56(4):1263-72. PubMed ID: 17393458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the management of lupus nephritis: let the treatment fit the patient.
    Bertsias G; Boumpas DT
    Nat Clin Pract Rheumatol; 2008 Sep; 4(9):464-72. PubMed ID: 18756272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New treatment strategies for proliferative lupus nephritis: keep children in mind!
    Ranchin B; Fargue S
    Lupus; 2007; 16(8):684-91. PubMed ID: 17711908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment options for proliferative lupus nephritis: an update of clinical trial evidence.
    Navaneethan SD; Viswanathan G; Strippoli GF
    Drugs; 2008; 68(15):2095-104. PubMed ID: 18840001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab in childhood systemic lupus erythematosus refractory to conventional immunosuppression: case report.
    Edelbauer M; Jungraithmayr T; Zimmerhackl LB
    Pediatr Nephrol; 2005 Jun; 20(6):811-3. PubMed ID: 15772840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on Lupus Nephritis: Core Curriculum 2020.
    Parikh SV; Almaani S; Brodsky S; Rovin BH
    Am J Kidney Dis; 2020 Aug; 76(2):265-281. PubMed ID: 32220510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric lupus nephritis: more options, more chances?
    Vachvanichsanong P; McNeil E
    Lupus; 2013 May; 22(6):545-53. PubMed ID: 23629826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.